Detalhe da pesquisa
1.
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
N Engl J Med
; 386(12): 1132-1142, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35179323
2.
Natural course of metastatic castration-resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone-sensitive setting.
Prostate
; 84(9): 888-892, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561317
3.
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade.
Cancer
; 130(9): 1642-1649, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180804
4.
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.
Cancer
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38564301
5.
A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR).
Oncologist
; 29(5): 450-e725, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452035
6.
Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.
N Engl J Med
; 385(22): 2036-2046, 2021 11 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34818478
7.
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial.
BMC Cancer
; 24(1): 493, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38637770
8.
Impact of androgen receptor alterations on cell-free DNA genomic profiling on survival outcomes in metastatic castration-resistant prostate cancer.
Prostate
; 83(16): 1602-1609, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37644774
9.
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell Carcinoma.
Oncologist
; 28(8): 737-e693, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36952231
10.
Papillary Renal Cell Carcinoma: A Review of Prospective Clinical Trials.
Curr Treat Options Oncol
; 24(9): 1199-1212, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407886
11.
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021).
Lancet Oncol
; 23(7): 899-909, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690072
12.
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
Oncologist
; 27(10): e815-e818, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036607
13.
Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022.
Curr Oncol Rep
; 24(9): 1201-1208, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438388
14.
Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.
Oncologist
; 26(12): 1006-e2129, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34423501
15.
Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform.
Oncologist
; 26(9): 751-760, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157173
16.
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer.
Oncologist
; 26(2): e270-e278, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33215787
17.
Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance.
Prostate
; 80(12): 1012-1023, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649013
18.
A Phase I Study of Alpha-1,3-Galactosyltransferase-Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma.
Oncologist
; 25(2): 121-e213, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043778
19.
Management of Nonmetastatic Castration-Resistant Prostate Cancer: Recent Advances and Future Direction.
Curr Treat Options Oncol
; 20(2): 14, 2019 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30741354
20.
Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High-Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial.
Oncologist
; 23(12): 1413-e151, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575560